Factory Supply LL-37 99% White Powder Raw peptide powder 1g 10g 1kg

Factory Supply LL-37 99% White Powder Raw peptide powder 1g 10g 1kg

Function and Usage of Liraglutide 204656-20-2

1、 Type 2 diabetes
Liraglutide improves control of blood glucose.It reduces meal-related hyperglycemia

(for 24 hours after administration) by increasing insulin secretion (only) when required by increasing

glucose levels, delaying gastric emptying, and suppressing prandial glucagon secretion.
In common to various degrees with other GLP-1 receptor agonists, liraglutide has advantages over

more traditional therapies for type 2 diabetes:

·  Liraglutide acts in a glucose-dependent manner, meaning it will stimulate insulin secretion only

when blood glucose levels are higher than normal, preventing "overshoot". Consequently, it shows

negligible risk of hypoglycemia.

·  Liraglutide has the potential for inhibiting apoptosis and stimulating regeneration of beta cells

(seen in animal studies).

·  Liraglutide decreases appetite and inhibits body weight gain, as shown in a head-to-head study

versus glimepiride.

·  Liraglutide lowers blood triglyceride levels.

2、Obesity
Liraglutide has been approved as an injectable adjunct to a reduced-calorie diet and increased

physical activity for chronic weight management in adult patients. The specified criteria are an

initial body mass index (BMI) of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater

(overweight), in the presence of at least one weight-related comorbid condition

(e.g.hypertension, type 2 diabetes mellitus, or dyslipidemia). In late 2014, data were reported from

the SCALE™ Obesity and Prediabetes trial, which is a randomised, double-blind, placebo-controlled,

multinational trial in non-diabetic people with obesity and non-diabetic people who are overweight

with comorbidities. In this phase 3a trial, there were 3,731 participants randomised to treatment

with liraglutide 3 mg or placebo, both in combination with diet and exercise. Those who completed

the 56-week trial achieved an average weight loss of 9.2%, to be compared with a 3.5% reduction in

the placebo group.

How is Retatrutide different from Semaglutide and Trizepatide ?

Mechanism:

1. Semaglutide work as (GLP-1) hormone agonist.

2. Tirezepatide work as (GLP-1 & GIP ) hormone agonist.

3. Retatrutide work as (GLP-1 & GIP & Glucagon) hormones agonist.

Weight loss in trials:

1. Semaglutide led to a 6-12% reduction in body weight in 28 weeks

2. Tirezepatide led to a 15-20% reduction in body weight in 72 weeks

3. Retatrutide led to a 25% reduction in body weight in 48 weeks

Why choose us?

​1. Higher quality products (>=99% purity) for most of peptides and raws. Quality Guaranteed: Many HPLC test reports are available (Janoshik).

2. Domestic warehouses and fast delivery.

3. Ship worldwide with safe and secure lines: 100% delivery guaranteed. No worry about Customs issues.

4. Special Service: Drop-shipping if need.

5. Cheapest prices in the market, unbeatable！

6. Many payment options: Paypal, bank transfer, alipay, wechat, bitcoin, USDT. 

put...